PDSB
Price
$1.09
Change
-$0.07 (-6.03%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
60.28M
76 days until earnings call
Intraday BUY SELL Signals
PRAX
Price
$278.60
Change
+$20.52 (+7.95%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
9.34B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PDSB vs PRAX

Header iconPDSB vs PRAX Comparison
Open Charts PDSB vs PRAXBanner chart's image
PDSB vs PRAX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PDSB vs. PRAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and PRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (PDSB: $1.17 vs. PRAX: $258.08)
Brand notoriety: PDSB and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 95% vs. PRAX: 375%
Market capitalization -- PDSB: $60.28M vs. PRAX: $9.34B
PDSB [@Biotechnology] is valued at $60.28M. PRAX’s [@Biotechnology] market capitalization is $9.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PDSB is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 4 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • PDSB’s TA Score: 4 bullish, 4 bearish.
  • PRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than PRAX.

Price Growth

PDSB (@Biotechnology) experienced а +6.36% price change this week, while PRAX (@Biotechnology) price change was -26.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

PDSB is expected to report earnings on Aug 18, 2026.

PRAX is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($9.34B) has a higher market cap than PDSB($60.3M). PDSB YTD gains are higher at: 51.988 vs. PRAX (-12.438). PDSB has higher annual earnings (EBITDA): -30.71M vs. PRAX (-357.2M). PRAX has more cash in the bank: 787M vs. PDSB (26.2M). PRAX has less debt than PDSB: PRAX (1.44M) vs PDSB (18M). PDSB (0) and PRAX (0) have equivalent revenues.
PDSBPRAXPDSB / PRAX
Capitalization60.3M9.34B1%
EBITDA-30.71M-357.2M9%
Gain YTD51.988-12.438-418%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.2M787M3%
Total Debt18M1.44M1,254%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBPRAX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PDSB
Daily Signal:
Gain/Loss:
PRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DWOIX21.90N/A
N/A
BNY Mellon Research Growth I
FAMEX53.85N/A
N/A
FAM Dividend Focus Fund Investor
GOCAX16.39N/A
N/A
Gabelli International Small Cap A
MSELX16.63N/A
N/A
Morgan Stanley Inst Emerging Mkts L
PLCGX17.17N/A
N/A
Principal LargeCap Growth I R6